170430 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines; Interleukins [IL] IL-10
THERAPEUTIC AGENT FOR CORONAVIRUS INFECTION
#2PEPTIDES WITH CYTOKINE-RELEASING ACTIVITY AND METHODS FOR CHARACTERIZING CYTOKINE-RELEASING PROFILES OF PEPTIDES
#3METHOD FOR SCREENING AND PREPARING IMMUNOMODULATOR
#4METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#5MMP-14 OR TIMP POTENCY ASSAY FOR MESENCHYMAL STEM CELLS
#6NEUTRALIZATION ANTIBODY ASSAY METHOD
#7MOUSE MODELS OF CYTOKINE RELEASE SYNDROME
#8METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#9SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#10BACTERIAL BIOSENSORS FOR DIAGNOSING AND TREATING INFLAMMATION
#11METHOD FOR EVALUATING QUALITY OF INDUCEMENT INHIBITORY-T-CELL FORMULATION
#12METHODS FOR DETECTING AND TREATING CEREBRAL CAVERNOUS MALFORMATION
#13BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSTIC TEST
#14TREATMENT OF AGING FRAILTY COMPRISING ADMINISTERING BONE MARROW DERIVED MESENCHYMAL STEM CELLS
#15DRAIN FLUIDS FOR DISEASE DIAGNOSIS AND MONITORING
#16ANTIGENIC TRIPEPTIDES DERIVED FROM MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS S-TYPE STRAINS, DERIVATIVES AND USES THEREOF
#17Blood Test to Screen Out Parkinson's Disease
#18PREDICTION OF STEM CELL THERAPY RESPONSIVENESS BY QUANTIFICATION OF PRE-EXISTING B REGULATORY CELLS
#19Precision Medicine Approach to Targeting Neurodegeneration
#20TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERS
#21METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#22INFLAMMATORY CYTOKINES AND FATIGUE IN SUBJECT WITH A COMPLEMENT MEDIATED DISEASE
#23METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#24SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID
#25Antigenic tripeptides derived from subsp. s-type strains, derivatives and uses thereof
#26METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#27DEVICE AND METHOD FOR DETECTING INFLAMMATION
#28METHODS AND PRODUCTS FOR TREATMENT OF GASTROINTESTINAL DISORDERS
#29METHOD FOR THE DETECTION OF CANCER
#30METHOD OF DETERMINING THE PROBABILITY OF INFLAMMATORY BOWEL DISEASE IN A SUBJECT BEING ULCERATIVE COLITIS OR CROHN'S DISEASE
#31METHOD FOR TREATING ATOPIC DERMATITIS USING MONOCLONAL STEM CELLS
#32USE OF PERIPHERAL BLOOD PRO- AND ANTI-INFLAMMATORY CYTOKINE RATIOS AS MARKERS OF IMPLANTATION PRECEDING PREGNANCY
#33Compositions and Methods to Detect Non-Coeliac Gluten Sensitivity
#34BIOMARKERS
#35USES OF IL-40 AND METHODS FOR DETECTING IL-40 ACTIVITY
#36BIOMARKER PANELS FOR ON-TREATMENT PREDICTION OF RESPONSE TO IMMUNO-ONCOLOGY DRUGS
#37METHODS, KITS AND COMPOSITIONS FOR CHARACTERIZING AN ANTI-INFLAMMATORY RESPONSE OF A PRODUCT
#38Method, Systems, and a Kit for Detection, Diagnosis, Monitoring and Treatment of COVID-19
#39DENDRITIC CELL POTENCY ASSAY
#40MODULATION OF SPLENOCYTES IN CELL THERAPY
#41KIT FOR DETECTING SUBSET OF HUMAN REGULATORY T CELL, AND DETECTION METHOD THEREOF
#42Diagnosis and risk stratification of fungal infections
#43METHODS FOR DETECTING, ASSESSING SEVERITY AND TREATING MULTIPLE SCLEROSIS
#44Biomarkers related to organ function
#45Methods and materials for assessing and treating cancer
#46INHIBITORS OF PROTEINS SPECIFIC FOR THE SECRETOME OF A CHONDROCYTE FOR USE IN THE TREATMENT OF BREAST CANCER METASTASIS
#47Antigenic tripeptides derived from subsp. s-type strains, derivatives and uses thereof
#48Insulin mimotopes and methods of using the same
#49Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
#50Blood Test for Screening Out Amyloid and Alzheimers Disease Presence
#51PPAR AGONIST OR LXR AGONIST FOR USE IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY MODULATION OF LAP ACTIVITY
#52Method for identifying a bacterial infection
#53BIOMARKERS
#54System for detecting infection in synovial fluid
#55IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy
#56Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
#57Method for diagnosing and treating fibromyalgia
#58Compositions and methods to detect non-coeliac gluten sensitivity
#59Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate
#60Modulation of splenocytes in cell therapy
#61LYMPHOID HEMOPATHY PROGNOSIS METHOD
#62BIOMARKERS FOR PREDICTING A RESPONSE TO AN IMMUNOMODULATING TREATMENT IN PATIENTS WITH INFLAMMATORY DISEASE
#63Insulin mimotopes and methods of using the same
#64Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment
#65DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#66Method for assessing protein identity and stability
#67Bioassay for the early detection of autoimmune diseases
#68METHODS OF IDENTIFYING ANTIGENS FOR VACCINES
#69Method and panel for determining acute kidney injury
#70Methods and compositions for T cell generation and uses thereof
#71METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#72METHODS AND DEVICES FOR DIAGNOSING OCULAR SURFACE INFLAMMATION AND DRY EYE DISEASE
#73METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#74Methods of Using Interleukin-10 for Treating Diseases and Disorders
#75CARBOHYDRATE-MODIFIED PARTICLES AND PARTICULATE FORMULATIONS FOR MODULATING AN IMMUNE RESPONSE
#76Biomarkers for Tuberculosis
#77Biomarkers related to organ function
#78Suppression of cytokine release and cytokine storm
#79Method for assessing protein identity and stability
#80DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#81Inhibitors of proteins specific for the secretome of a chondrocyte for use in the treatment of breast cancer metastasis
#82Biological specimen evaluation methods using cytology and immunology
#83Method for identifying a bacterial infection
#84PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#85Process for assessing risk of substance administration
#86Method and kit for cytokine analysis from a human whole blood sample
#87Method and biomarkers for the detection of dengue hemorrhagic fever
#88Methods for determining risk of chronic lung allograft dysfunction (CLAD) and subtypes thereof
#89METHODS OF TREATING IPEX SYNDROME USING TOXIN-BASED PHARMACEUTICAL COMPOSITIONS
#90Method for the detection of an albumin isoform
#91Method for diagnosing fibromyalgia
#92DETERMINATION OF EFFICIENT TIME(S) FOR CHEMOTHERAPY DELIVERY
#93CANCER PROGNOSTIC ASSAYS
#94Microfluidic device for generating neural cells to simulate post-stroke conditions
#95THERAPEUTIC STRATEGY FOR TREATING AUTOIMMUNE AND DEGENERATIVE DISEASES
#96BIOMARKERS FOR LOWER URINARY TRACT SYMPTOMS (LUTS)
#97Biomarkers
#98System for detecting infection in synovial fluid
#99METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#100Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
#101Method for the diagnosis of and/or monitoring mucormycosis
#102Compositions and methods related to S100A12
#103Methods and biomarkers for the detection of dengue hemorrhagic fever
#104PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#105DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#106Abrogating HIV-1 Infection via Drug-Induced Reactivation of Apoptosis
#107Bioassay for the early detection of autoimmune diseases
#108Urinary biomarkers for cancer diagnosis
#109Biomarker for treating cancer patients
#110Therapeutic Use Of Probiotics
#111Modulation of splenocytes in cell therapy
#112VEHICLE FOR DELIVERING A COMPOUND TO A MUCOUS MEMBRANE AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#113Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
#114Process for the measurement of the potency of glatiramer acetate
#115Method for assessing risk of heart failure
#116Molecular phenotyping of severe asthma
#117Process for the measurement of the potency of glatiramer acetate
#118Methods to Treat Disease States by Influencing the Signaling of Ox-40-Receptors and High Throughput Screening Methods for Identifying Substances Therefor
#119Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases